Want to join the conversation?
$BMY said that in April, it acquired Padlock Therapeutics, Inc., a private Massachusetts-based biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases. In March, the company entered into an agreement with LabCentral to become a LabCentral platinum sponsor.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.